Ciliary Dyskinesia-Bronchiectasis Symptoms, Doctors, Treatments, Advances & More

Learn About Ciliary Dyskinesia-Bronchiectasis

What is the definition of Ciliary Dyskinesia-Bronchiectasis?

Primary ciliary dyskinesia (PCD) is a genetic disorder characterized by chronic respiratory tract infections. In individuals with primary ciliary dyskinesia, the tiny hair-like structures (cilia) that protect the lungs and other tissues have mutations that prevent them from working properly, eventually leading to a condition where the bronchial tubes in the lungs are permanently damaged (bronchiectasis).

Save information for later

What are the symptoms of Ciliary Dyskinesia-Bronchiectasis?

Symptoms of primary ciliary dyskinesia include a persistent wet cough from birth or infancy, neonatal respiratory distress, shortness of breath, wheezing or whistling upon breathing, recurrent chest colds, asthma, chronic nasal drainage, hearing problems, and chronic infections in the ears, sinuses, and lungs that eventually lead to the development of bronchiectasis (permanent bronchial tube damage). Additional symptoms may include infertility or a condition where organs, such as the heart, liver, or other organs, are either reversed in the body (situs inversus) or abnormally formed.

Not sure about your diagnosis?

Check Your Symptoms

What are the current treatments for Ciliary Dyskinesia-Bronchiectasis?

While there is no cure for primary ciliary dyskinesia, treatment is focused on alleviating symptoms and may include antibiotics for sinus or lung infections, bronchodilators, steroids, and mucous thinners (mucolytics), oxygen therapy, airway clearance techniques, speech therapy, hearing aids, and physical therapy. Surgery may be necessary to correct any heart defects, while lung transplantation may be considered for patients with severe, advanced bronchiectasis (permanently damaged bronchial tubes).

Who are the top Ciliary Dyskinesia-Bronchiectasis Local Doctors?

Jane A. Lucas

Elite

Highly rated in

conditions

NIHR Southampton Biomedical Research Centre

Southampton, GB

Jane Lucas is in Southampton, United Kingdom. Lucas is rated as an Elite expert by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. She is also highly rated in 13 other conditions, according to our data. Her top areas of expertise are Drug Induced Dyskinesia, Ciliary Dyskinesia-Bronchiectasis, Situs Inversus, and Dextrocardia with Situs Inversus.

View Profile

Michael R. Loebinger

Elite

Highly rated in

conditions

Royal Brompton And Harefield NHS Foundation Trust

Michael Loebinger is in United Kingdom. Loebinger is rated as an Elite expert by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. He is also highly rated in 14 other conditions, according to our data. His top areas of expertise are Bronchiectasis, Ciliary Dyskinesia-Bronchiectasis, Drug Induced Dyskinesia, and Nontuberculous Mycobacterial Lung Disease.

View Profile

Learn about our expert tiers

Learn more

Dr. Michael R. Knowles

Pulmonary Medicine

Elite

Highly rated in

conditions

Pulmonary Medicine

UNC Health

UNC Hospitals Pulmonary Specialty Clinic

300 Meadowmont Village Cir

Chapel Hill, NC 27517

Michael Knowles is a Pulmonary Medicine doctor in Chapel Hill, North Carolina. Dr. Knowles has been practicing medicine for over 51 years and is rated as an Elite doctor by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. He is also highly rated in 6 other conditions, according to our data. His top areas of expertise are Ciliary Dyskinesia-Bronchiectasis, Kartagener Syndrome, Bronchiectasis, and Cystic Fibrosis. He is licensed to treat patients in North Carolina. Dr. Knowles is currently accepting new patients.

View Profile

View All Doctors

What are the latest Ciliary Dyskinesia-Bronchiectasis Clinical Trials?

Does Addition of Oscillatory Positive Expiratory Pressure (OPEP) Device to a Chest Physiotherapy Program Provide Further Health Benefits in Children With Bronchiectasis?

Status: Recruiting

Start Date: September 6, 2021

Intervention Type: Device, Other

Phase: Not Applicable

View Trial

Summary: Oscillatory positive expiratory pressure (OPEP) devices such as Flutter®, Aerobika® or Shaker ® are commonly prescribed in the clinical practice for airway clearance in children with chronic lung diseases including bronchiectasis, cystic fibrosis, and primary ciliary dyskinesia. Health insurance companies may cover these devices in some countries; but this is not a common practice around the world...

Match to trials

Find the right clinical trials for you in under a minute

Get started

The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)

Status: Recruiting

Start Date: March 2, 2020

View Trial

Summary: The Ear-Nose-Throat (ENT) Prospective International Cohort of patients with Primary Ciliary Dyskinesia (EPIC-PCD) is a prospective observational clinical cohort study, set up as a multinational multi-centre study. It is embedded into routine patient care of participating reference centres for PCD and patients keep being managed according to local procedures and guidelines.

View All Clinical Trials

What are the Latest Advances for Ciliary Dyskinesia-Bronchiectasis?